The Cigna Group (NYSE:CI) Shares Purchased by AustralianSuper Pty Ltd

AustralianSuper Pty Ltd grew its position in The Cigna Group (NYSE:CI) by 10.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,647 shares of the health services provider’s stock after acquiring an additional 1,068 shares during the period. AustralianSuper Pty Ltd’s holdings in The Cigna Group were worth $4,035,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Kovack Advisors Inc. purchased a new stake in The Cigna Group in the 1st quarter worth $214,000. Ashton Thomas Private Wealth LLC raised its position in shares of The Cigna Group by 4.1% during the 1st quarter. Ashton Thomas Private Wealth LLC now owns 3,012 shares of the health services provider’s stock worth $1,094,000 after purchasing an additional 119 shares during the last quarter. Norden Group LLC raised its position in shares of The Cigna Group by 22.3% during the 1st quarter. Norden Group LLC now owns 2,355 shares of the health services provider’s stock worth $855,000 after purchasing an additional 429 shares during the last quarter. J.W. Cole Advisors Inc. boosted its holdings in The Cigna Group by 33.2% in the 1st quarter. J.W. Cole Advisors Inc. now owns 3,044 shares of the health services provider’s stock worth $1,106,000 after buying an additional 759 shares during the last quarter. Finally, Diversify Advisory Services LLC purchased a new stake in The Cigna Group during the 1st quarter worth approximately $2,394,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director William J. Delaney III sold 2,691 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares in the company, valued at $6,010,264.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.60% of the stock is owned by insiders.

The Cigna Group Trading Up 0.6 %

NYSE:CI opened at $314.91 on Friday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73. The Cigna Group has a 52-week low of $253.95 and a 52-week high of $370.83. The stock’s 50 day moving average price is $346.52 and its 200 day moving average price is $341.77. The company has a market capitalization of $89.46 billion, a PE ratio of 25.85, a P/E/G ratio of 1.05 and a beta of 0.50.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share for the quarter, topping analysts’ consensus estimates of $6.42 by $0.30. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The firm had revenue of $60.52 billion during the quarter, compared to analysts’ expectations of $58.30 billion. During the same quarter in the prior year, the business earned $6.13 EPS. The Cigna Group’s quarterly revenue was up 24.6% compared to the same quarter last year. On average, research analysts anticipate that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be paid a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.78%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio is presently 45.98%.

Wall Street Analysts Forecast Growth

CI has been the topic of several recent research reports. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 2nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a report on Wednesday, October 23rd. JPMorgan Chase & Co. lifted their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 21st. Barclays raised their target price on The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Finally, Stephens reissued an “overweight” rating and set a $410.00 price target on shares of The Cigna Group in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $392.79.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.